/Investor DB

Mayo Clinic Ventures — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Evelo BiosciencesinJan 2017

BiotechCambridge, US

Jennifer Glennon(Executive Officer)inBalkrishan (Simba) Gill, Ph.D.(Executive Officer, Director)Duncan McHale(Executive Officer)inWilliam DeVaul(Executive Officer)inMark Bodmer, Ph.D.(Executive Officer)

BoardNoubar B. Afeyan, Ph.D.(Director)

Co-investorsGV (Google Ventures)SV Health InvestorsAlexandriaFlagship PioneeringKaiser Permanente Ventures

Glookoglooko.comin𝕏Jun 2017

Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring.

Digital HealthHealthtechSaaSPalo Alto, US

Clay Davidson(Executive Officer)inPrakash Menon(Executive Officer)inEd Marshall(Executive Officer)David Pass(Executive Officer)inAdam Hameed(Executive Officer)inMark Beucler(Executive Officer)in

Co-investorsCanaan PartnersHealth Catalyst CapitalRealization Capital PartnersSamsung NextGeorgianSocial Capital Partnership

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.